{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:09:57Z","timestamp":1777342197462,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["3200300_135539"],"award-info":[{"award-number":["3200300_135539"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009575","name":"Jacques und Gloria Gossweiler-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009575","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1115-4","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T13:03:42Z","timestamp":1560258222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Satellite cell content in Huntington\u2019s disease patients in response to endurance training"],"prefix":"10.1186","volume":"14","author":[{"given":"Sandro Manuel","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Frese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens A.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ligon-Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Aguayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fl\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Toigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"1115_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol. 1998;43:397\u2013400.","journal-title":"Ann Neurol"},{"key":"1115_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/mds.27031","volume":"32","author":"SM Gehrig","year":"2017","unstructured":"Gehrig SM, Petersen JA, Frese S, et al. Skeletal muscle characteristics and mitochondrial function in Huntington's disease patients. Mov Disord. 2017;32:1258\u20139.","journal-title":"Mov Disord"},{"key":"1115_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","volume":"48","author":"R Lodi","year":"2000","unstructured":"Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol. 2000;48:72\u20136.","journal-title":"Ann Neurol"},{"key":"1115_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/mds.20373","volume":"20","author":"C Saft","year":"2005","unstructured":"Saft C, Zange J, Andrich J, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord. 2005;20:674\u20139.","journal-title":"Mov Disord"},{"key":"1115_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fphys.2014.00380","volume":"5","author":"D Zielonka","year":"2014","unstructured":"Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle pathology in Huntington\u2019s disease. Front Physiol. 2014;5:380.","journal-title":"Front Physiol"},{"key":"1115_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fphys.2017.00127","volume":"8","author":"M Mielcarek","year":"2017","unstructured":"Mielcarek M, Smolenski RT, Isalan M. Transcriptional signature of an altered purine metabolism in the skeletal muscle of a Huntington\u2019s disease mouse model. Front Physiol. 2017;8:127.","journal-title":"Front Physiol"},{"key":"1115_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40169-015-0076-z","volume":"4","author":"M Mielcarek","year":"2015","unstructured":"Mielcarek M, Isalan M. A shared mechanism of muscle wasting in cancer and Huntington\u2019s disease. Clin Transl Med. 2015;4:34.","journal-title":"Clin Transl Med"},{"key":"1115_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jns.2015.09.351","volume":"358","author":"E Cubo","year":"2015","unstructured":"Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-P\u00e9rez N. Body composition analysis as an indirect marker of skeletal muscle mass in Huntington\u2019s disease. J Neurol Sci. 2015;358:335\u20138.","journal-title":"J Neurol Sci"},{"key":"1115_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00415-016-8310-1","volume":"264","author":"S Frese","year":"2017","unstructured":"Frese S, Petersen JA, Ligon-Auer M, et al. Exercise effects in Huntington disease. J Neurol. 2017;264:32\u20139.","journal-title":"J Neurol"},{"key":"1115_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","volume":"47","author":"RE Pratley","year":"2000","unstructured":"Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary energy expenditure in patients with Huntington\u2019s disease. Ann Neurol. 2000;47:64\u201370.","journal-title":"Ann Neurol"},{"key":"1115_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00415-015-7753-0","volume":"262","author":"SD S\u00fcssmuth","year":"2015","unstructured":"S\u00fcssmuth SD, M\u00fcller VM, Geitner C, et al. Fat-free mass and its predictors in Huntington\u2019s disease. J Neurol. 2015;262:1533\u201340.","journal-title":"J Neurol"},{"key":"1115_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13023-017-0740-z","volume":"12","author":"SM Mueller","year":"2017","unstructured":"Mueller SM, Gehrig SM, Petersen JA, et al. Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients. Orph J Rare Dis. 2017;12:184.","journal-title":"Orph J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1115-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T23:27:21Z","timestamp":1591745241000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1115-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1115-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients and participants had completed a routine health questionnaire and were informed about the applied procedures and the associated risks. Patients and participants provided written informed consent for participation in the study. All experiments were approved by the local ethics committee and the study was performed in accordance with the ethical standards laid down in the Declarations of Helsinki for human experimentation. This trial was registered on  (NCT01879267).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}